SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,079.96 113.61
( 0.15%)

Global Indices

Nasdaq

53,790.86 -21.99
(-0.04%)

Dow Jones

7,769.71 20.51
(0.26%)

Hang Seng

68,341.16 817.10
(1.21%)

Nikkei 225

10,757.72 -75.43
(-0.70%)

Forex

USD-INR

95.38 0.10
(0.10%)

EUR-INR

110.06 0.02
(0.01%)

GBP-INR

128.81 0.17
(0.13%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

36.4616629

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

47.39

14172.7

EPS(TTM)

Face Value()

Div & Yield %

6.6

0.29

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	1341.48	1174.37	853.27	655.20	658.29	599.55
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1341.48	1174.37	853.27	655.20	658.29	599.55
Other Income	103.53	65.79	62.07	60.48	42.25	31.16
Stock Adjustments	-3.30	-0.70	7.25	10.19	-3.89	-0.55
Total Income	1441.71	1239.46	922.59	725.87	696.65	630.16
EXPENDITURE :
Raw Materials	675.49	639.24	486.18	404.64	373.70	337.36
Power & Fuel Cost	32.95	30.73	26.04	14.24	11.49	10.90
Employee Cost	121.98	101.68	77.19	56.09	60.46	54.64
Other Manufacturing Expenses	65.94	64.62	46.10	21.09	5.25	6.98
Selling & Administrative Expenses	96.71	112.99	73.19	61.54	67.57	60.08
Miscellaneous Expenses	21.55	16.32	11.88	15.89	22.22	15.31
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1014.62	965.58	720.58	573.49	540.68	485.28
Operating Profit	427.10	273.88	202.01	152.38	155.97	144.87
Interest	1.33	1.17	0.99	3.61	3.80	5.35
Gross Profit	425.77	272.71	201.02	148.77	152.17	139.52
Depreciation	34.23	29.45	29.13	16.74	17.66	15.19
Profit Before Tax	391.54	243.26	171.89	132.03	134.51	124.33
Tax	86.29	52.14	37.46	29.34	30.02	28.19
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.55	2.84	0.68	-0.17	0.50	-2.24
Reported Net Profit	300.70	188.27	133.76	102.87	103.99	98.38
Extraordinary Items	1.43	0.81	0.07	-0.05	0.00	0.03
Adjusted Net Profit	299.27	187.46	133.69	102.92	103.99	98.35
Adjustment below Net Profit	1.04	-0.30	0.28	-8.64	0.05	-0.20
P & L Balance brought forward	505.78	345.00	233.61	155.21	61.41	-32.69
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	36.25	27.19	22.66	15.82	10.23	4.09
P & L Balance carried down	771.26	505.78	345.00	233.61	155.21	61.41
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	90.00	80.00	60.00	50.00	25.00	25.00
Dividend Per Share(Rs)	0.90	0.80	0.60	0.50	0.25	0.25
Earnings Per Share-Unit Curr	6.64	4.15	2.95	2.27	2.54	2.40
Earnings Per Share(Adj)-Unit Curr	6.64	4.15	2.95	2.27	2.54	2.40
Book Value-Unit Curr	36.46	30.53	26.98	24.52	16.90	14.65
Book Value(Adj)-Unit Curr	36.46	30.53	26.98	24.52	16.90	14.65

78,079.96 113.61 ( 0.15%)

53,790.86 -21.99 (-0.04%)

7,769.71 20.51 (0.26%)

68,341.16 817.10 (1.21%)

10,757.72 -75.43 (-0.70%)

95.38 0.10 (0.10%)

110.06 0.02 (0.01%)

128.81 0.17 (0.13%)

0.60 0.00 (-0.21%)